GOLDMAN SACHS GROUP INC - SEELOS THERAPEUTICS INC ownership

SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 84 filers reported holding SEELOS THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of SEELOS THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$24,023
+70.1%
20,103
-1.6%
0.00%
Q1 2023$14,127
-1.4%
20,438
-3.1%
0.00%
Q4 2022$14,322
-42.7%
21,093
-12.1%
0.00%
Q3 2022$25,000
-75.7%
24,003
-84.1%
0.00%
Q2 2022$103,000
-6.4%
151,335
+15.0%
0.00%
Q1 2022$110,000
-56.9%
131,609
-16.1%
0.00%
Q4 2021$255,000
+8.5%
156,833
+60.6%
0.00%
Q3 2021$235,000
-48.1%
97,645
-43.1%
0.00%
Q2 2021$453,000
-58.5%
171,595
-21.5%
0.00%
Q1 2021$1,091,000
+1002.0%
218,611
+250.1%
0.00%
Q4 2020$99,00062,4410.00%
Other shareholders
SEELOS THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
GENDELL JEFFREY L 4,908,725$3,333,0240.30%
Oasis Management Co Ltd. 850,000$577,1500.12%
AdvisorShares Investments LLC 373,083$253,3230.07%
Uniplan Investment Counsel, Inc. 1,177,510$7990.06%
1492 Capital Management LLC 98,061$66,5830.04%
Strategic Family Wealth Counselors, L.L.C. 102,000$69,2580.03%
Modera Wealth Management, LLC 871,505$591,7520.02%
Sovereign Financial Group, Inc. 75,000$50,9250.02%
MAI Capital Management 1,022,008$693,9430.01%
GSA CAPITAL PARTNERS LLP 105,050$710.01%
View complete list of SEELOS THERAPEUTICS INC shareholders